RIGL vs YUM · P/E 9.1, rev $137.5M vs P/E 29, rev $2.17B
Rigel Pharmaceuticals Inc (RIGL) versus Yum! Brands Inc (YUM) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Yum! Brands Inc (YUM) is a restaurants company listed on US.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported YUM revenue for 2026-06-30 was $2.17B. Net income was $853.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. YUM currently screens at market cap $41.43B and trailing P/E 29.4.
Not investment advice. Open the RIGL and YUM stock pages for the full models.
Not investment advice.